Social Anxiety Disorder and Phased Treatment

This study is being conducted with qualified individuals 18 – 65 years old suffering from social anxiety disorder. The study explores how the FDA-approved medication paroxetine (Paxil) affects coping behaviors men and women typically use to deal with anxiety in social situations. Participants will be asked to attend 10 sessions over the course of 22 weeks, as well as two follow-up visits at 3 and 6 months following the medication phase. 80 subjects will be recruited – 40 at the Medical University of South Carolina and 40 at the University of Minnesota.
Source: MUSC Mental Health Podcast - Category: Psychiatry Authors: Source Type: podcasts